Clinical Trial Update: Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a vaccine therapy following therapeutic autologous lymphocytes and cyclophosphamide in metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Autologous tumor cell vaccine (autologous tumor cell vaccine)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 1 | Status: COMPLETED